Enanta Pharmaceuticals(DE:9EP)
€10.40+0.50 (+5.05%)
DE:9EP
Enanta Pharmaceuticals earnings date
€10.40
At close:+0.50 (+5.05%)
Enanta Pharmaceuticals (9EP) Q3 2018 Earnings Report
0 Followers
DE:9EP Q3 2018 EPS Results
- Actual EPS
- EUR 0.88
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.40
DE:9EP Q3 2018 Revenue Results
- Actual Revenue
- EUR 51.76M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 08/07/2018
- Time
- After Close
- Conference Call
- Tuesday, August 7, 2018
DE:9EP Upcoming Earnings
Enanta Pharmaceuticals's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:9EP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q4) | -0.65- | -0.79 | ― | ― |
| Aug 10, 2026 | 2026 (Q3) | -0.46-0.61 | -0.77 | 21.18% (+0.16) | |
| May 11, 2026 | 2026 (Q2) | -0.44-0.41 | -0.96 | 57.55% (+0.55) | |
| Feb 09, 2026 | 2026 (Q1) | -0.69-0.38 | -0.95 | 60.00% (+0.57) | |
| Nov 17, 2025 | 2025 (Q4) | -0.92-0.79 | -1.23 | 36.03% (+0.44) | |
| Aug 11, 2025 | 2025 (Q3) | -0.81-0.77 | -0.97 | 20.56% (+0.20) | |
| May 12, 2025 | 2025 (Q2) | -1.04-0.96 | -1.33 | 27.89% (+0.37) | |
| Feb 10, 2025 | 2025 (Q1) | -1.22-0.95 | -1.43 | 33.54% (+0.48) | |
| Nov 25, 2024 | 2024 (Q4) | -1.05-1.23 | -1.2 | -2.26% (-0.03) | |
| Aug 05, 2024 | 2024 (Q3) | -1.29-0.97 | -1.68 | 42.47% (+0.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
